Paris, FRANCE
More info
Innate Pharma announces today the outcome of its annual general meeting, including changes in the composition of its Supervisory Board
June 23, 2009
- Innate Pharma held its annual general meeting on June 23, 2009
- All proposed resolutions were voted according to management’s recommendations
- Mrs. Irina Staatz-Granzer joins the Supervisory Board as a new, independent member
- Mr. Patrick Van Beneden, from GIMV, an investor, is appointed as observer to the Supervisory Board for a one-year period
| Download Area |
|---|
| PR in english |
| CP en français |